ArticleResearch square2026
Spatiotemporal cell type deconvolution leveraging tissue structure.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Spot-based spatial transcriptomics (ST) captures aggregated transcriptomic profiles at spatial locations (spots) in tissues. Deconvolution methods are needed to estimate the proportion of each cell type in every spot, and usually leverage a single cell transcriptomic reference (scRNA-seq). Though there are an increasing number of experiments that profile multiple adjacent tissue slices, no deconvolution method leverages 3D tissue structure. Some methods utilize the 2D spatial organization assuming neighboring spots are similar, which is not the case in heterogeneous environments. Moreover, most methods aggregate reference scRNA-seq profiles of the same cell type, missing subtle cell state variations. We present SpaDecoder, a parallelized per-spot deconvolution method for multiple neighboring spatial or temporal ST slices that predicts cell type proportions with a matrix factorization-based objective. SpaDecoder uses slice alignment, per-spot spatio-transcriptomic neighborhood inference, and 3D spatial Gaussian kernel weights to effectively leverage 3D structure and adapt to heterogeneous tissue environments. We model individual scRNA-seq profiles, instead of cell type aggregated, to capture cell state variability. The mathematical framework of SpaDecoder supports several downstream analyses. It uncovers key cell type regions and changing composition across slices, identifies colocalized cell types, imputes spatial gene expression, and predicts 3D spatio-temporal scRNA-seq cell locations. SpaDecoder outperforms other methods on various metrics, datasets, scenarios, and ablations, and yields interpretable biology, showing it harnesses 3D structure and single cell reference profiles to improve deconvolution. SpaDecoder is available at https://github.com/ZhangLabGT/spadecoder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.